Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455747) titled 'Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System' on March 3.
Study Type: Observational [Patient Registry]
Primary Sponsor: Boston Scientific Corporation
Condition:
Extracranial Carotid Artery Disease
TCAR
Transcarotid Artery Revascularization
Intervention:
Device: Use of ENROUTE™ Transcarotid Neuroprotection System in conjunction with any commercially available Boston Scientific stent marketed for treatment of carotid artery disease
Recruitment Status: Not recruiting
Date of First Enrollment: May 2026
Target Sample Size: 5000
To...